GAM Holding AG - INSYS THERAPEUTICS INC NEW ownership

INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 118 filers reported holding INSYS THERAPEUTICS INC NEW in Q2 2017. The put-call ratio across all filers is 1.58 and the average weighting 0.0%.

Quarter-by-quarter ownership
GAM Holding AG ownership history of INSYS THERAPEUTICS INC NEW
ValueSharesWeighting
Q1 2019$388,000
+32.0%
83,9400.0%0.02%
+6.7%
Q4 2018$294,000
-65.2%
83,9400.0%0.02%
-51.6%
Q3 2018$846,000
+39.1%
83,9400.0%0.03%
+47.6%
Q2 2018$608,000
+19.9%
83,9400.0%0.02%
+16.7%
Q1 2018$507,000
-37.3%
83,9400.0%0.02%
-28.0%
Q4 2017$808,000
+8.5%
83,9400.0%0.02%
-19.4%
Q3 2017$745,000
-29.8%
83,9400.0%0.03%
+93.8%
Q2 2017$1,062,000
+20.4%
83,9400.0%0.02%
+14.3%
Q1 2017$882,000
+14.2%
83,9400.0%0.01%0.0%
Q4 2016$772,000
-21.9%
83,9400.0%0.01%
-17.6%
Q3 2016$989,000
-8.8%
83,9400.0%0.02%0.0%
Q2 2016$1,085,000
-19.1%
83,9400.0%0.02%
-22.7%
Q1 2016$1,341,000
-44.2%
83,9400.0%0.02%
-40.5%
Q4 2015$2,403,000
+0.6%
83,9400.0%0.04%
-9.8%
Q3 2015$2,389,000
-20.8%
83,9400.0%0.04%
-6.8%
Q2 2015$3,016,000
+23.6%
83,940
+100.0%
0.04%
+18.9%
Q1 2015$2,440,000
+37.9%
41,9700.0%0.04%
+42.3%
Q4 2014$1,769,000
+8.7%
41,9700.0%0.03%
+8.3%
Q3 2014$1,628,000
+24.2%
41,9700.0%0.02%
+20.0%
Q2 2014$1,311,000
-24.6%
41,9700.0%0.02%
-28.6%
Q1 2014$1,739,000
+60.6%
41,970
+50.0%
0.03%
+47.4%
Q4 2013$1,083,000
+10.7%
27,9800.0%0.02%
+5.6%
Q3 2013$978,000
+152.7%
27,9800.0%0.02%
+125.0%
Q2 2013$387,00027,9800.01%
Other shareholders
INSYS THERAPEUTICS INC NEW shareholders Q2 2017
NameSharesValueWeighting ↓
Consonance Capital Management LP 3,257,094$92,697,00013.04%
JW Asset Management, LLC 388,346$11,052,0004.00%
Anson Funds Management LP 400,200$11,390,0003.31%
Orbimed Advisors 4,081,800$116,168,0001.17%
SCOPIA CAPITAL MANAGEMENT LP 1,718,487$48,908,0001.05%
Bellevue Asset Management AG 210,000$5,977,0000.98%
NEXT CENTURY GROWTH INVESTORS LLC 788,534$22,441,0000.93%
Rock Springs Capital Management LP 308,000$8,766,0000.71%
JUNCTURE WEALTH STRATEGIES, LLC 18,502$527,0000.43%
B. Riley Wealth Management, Inc. 8,600$244,0000.35%
View complete list of INSYS THERAPEUTICS INC NEW shareholders